Motion Sickness Drugs Market size to record USD 136.49 million growth from 2023-2027, Advent of nauseogenic information technology is one of the key market trends, Technavio

NEW YORK, May 3, 2024 /PRNewswire/ -- The global motion sickness drugs market size is estimated to grow by USD 136.49 million from 2023 to 2027, according to Technavio. This growth is expected to occur at a Compound Annual Growth Rate (CAGR) of 4.43% during the forecast period.

To understand more about this market - Download a FREE Sample Report in minutes!

Key Trends Fueling Growth

• Advent of nauseogenic information technology: 
• Motion sickness remains a problem for travelers. Current treatments are not great, but progress in brain imaging and neuropharmacology could lead to better drugs. Understanding the brain better helps. MRI helps study different parts of the brain involved.
• Nauseogenic technology can help too. It uses vehicles to study stability, showing how the body stays stable. It found that motion sickness happens at certain frequencies, similar to natural body movements. This research is new, but more advances are expected. It could help make better motion sickness drugs in the future.

For more insights on the market trends with forecast market size and historic data (2017 - 2021) - Download a FREE Sample Report in minutes!

Major Challenges:

• Nonpharmacological countermeasures to treat motion sickness 
• Nonpharmacological strategies such as habituation and behavioral training are effective in combating motion sickness. Habituation training involves exposing individuals to prolonged motion stimulation, like parabolic flight or virtual reality, to induce habituation. This training aims to simulate sensory conflict to prevent motion sickness. Behavioral training includes techniques such as focusing on a distant horizon, controlled breathing, and listening to soothing music.
• These methods help balance visual and vestibular information, reducing symptoms. Pilots with specific dietary patterns are more prone to airsickness, but a protein-rich beverage prior to stimulation can alleviate symptoms. Vitamin C and acupuncture have also shown effectiveness in treating motion sickness.
• Additionally, transcutaneous electrical nerve stimulation can suppress symptoms and improve cognitive function. These nonpharmacological approaches are valuable for managing motion sickness, reducing the need for pharmacological interventions.

To know more about the market opportunities impacted by market dynamics, click here to- Download a FREE Sample Report in minutes!

Analyst Review

The Motion Sickness Drugs Market is witnessing notable traction due to unmet healthcare needs among individuals experiencing discomfort, anxiety, and nausea during multi-axial motion. Pregnant women, children, and cancer patients are particularly susceptible. Drug classes like antihistaminic and anticholinergic drugs, available orally or through transdermal patches, are preferred. Popular options include dimenhydrinate, meclizine, and scopolamine.

With increased demand in developed economies, online providers and retail pharmacies are catering to consumers, offering relief bands and traditional medicines. Factors like route of administration and incidence of motion sickness influence market dynamics. Healthcare systems are integrating pharmacological therapies into treatment regimens.

In regions like the Virgin Islands and Saint Maarten, access to prescription drugs is expanding. As females seek effective solutions, wearable devices like Reliefband and Reliefband Sport gain popularity. Overall, the market for motion sickness drugs is growing steadily, driven by the need for convenient and accessible remedies.

Market Overview

In the Motion Sickness Drugs Market, demand for relief bands and drugs, whether transdermal or oral, is accelerating due to the temporary sensation of discomfort experienced by individuals. This sensation often affects the eyes and is linked to the coronavirus pandemic. Acetylcholine plays a crucial role in this condition. Online pharmacies are witnessing increased demand dynamics for these medications.

Wearable relief bands are gaining traction for their convenience. As more people seek solutions for motion sickness, the market for these drugs is expanding rapidly. With the ease of access provided by online platforms, consumers are increasingly turning to transdermal and oral drugs to alleviate their symptoms. As a result, the motion sickness drugs market is experiencing significant growth.

Start exploring market insights by Download a FREE Sample Report in minutes!

Key Topics Covered:

 1 Executive Summary
 2 Market Landscape
 3 Market Sizing
 4 Historic Market Size
 5 Five Forces Analysis
 6 Market Segmentation

• Product 
• Antihistamines
• Anticholinergics
• Distribution Channel
• Offline
• Online
• Geography 
• North America
• Europe
• Asia
• Rest Of World (ROW)

 7 Customer Landscape
 8 Geographic Landscape
 9 Drivers, Challenges, and Trends
10 Venodr Landscape
11 Vendor Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED